CA
YARW

Centerpoint Advisors’s Yarrow Bioscience YARW Stock Holding History

Centerpoint Advisors’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
7
– – ﹤0.01% 437
2026
Q1 		$0 Hold
7
– – ﹤0.01% 432
2025
Q4 		$0 Hold
7
– – ﹤0.01% 477
2025
Q3 		$0 Hold
7
– – ﹤0.01% 467
2025
Q2 		$1K Hold
7
– – ﹤0.01% 382
2025
Q1 		$1K Hold
7
– – ﹤0.01% 380
2024
Q4 		$1K Hold
7
– – ﹤0.01% 443
2024
Q3 		$1K Hold
7
– – ﹤0.01% 461
2024
Q2 		$1K Buy
+7
New +$873 ﹤0.01% 431

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Centerpoint Advisors's YARW Position: Q2 2026 in Review

Centerpoint Advisors held its Yarrow Bioscience (YARW) position steady in Q2 2026 at 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #437.

Centerpoint Advisors first reported a position in YARW in Q2 2024 and has held it in 9 quarters since. The position peaked at $1K in Q2 2025. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Centerpoint Advisors held 7 shares of Yarrow Bioscience worth $0 as of Q2 2026.
  • Centerpoint Advisors left its Yarrow Bioscience share count unchanged in Q2 2026.
  • Yarrow Bioscience made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #437 holding.
  • Centerpoint Advisors first reported a position in Yarrow Bioscience in Q2 2024 and has held it in 9 quarters since.
  • Centerpoint Advisors's Yarrow Bioscience position peaked at $1K in Q2 2025.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.